Structures of the Complexes of a Potent Anti-HIV Protein
Cyanovirin-N and High Mannose Oligosaccharides*
Istvan
Botos
,
Barry R.
O'Keefe§,
Shilpa R.
Shenoy§,
Laura K.
Cartner¶,
Daniel M.
Ratner
**,
Peter H.
Seeberger

,
Michael R.
Boyd§§, and
Alexander
Wlodawer
¶¶
From the
Macromolecular Crystallography Laboratory,
NCI, National Institutes of Health, Frederick, Maryland
21702-1201, § Molecular Targets Drug Discovery Program,
Center for Cancer Research, NCI-Frederick, National Institutes of
Health, Frederick, Maryland 21702, ¶ Intramural Research Support
Program, SAIC-Frederick, Frederick, Maryland 21702,
Department
of Chemistry, Massachusetts Institute of Technology, Cambridge,
Massachusetts 02139, and the §§ USA Cancer
Research Institute, College of Medicine, University of South Alabama,
Mobile, Alabama 36688
The development of anti-human immunodeficiency
virus (HIV) microbicides for either topical or ex vivo use
is of considerable interest, mainly due to the difficulties in creating
a vaccine that would be active against multiple clades of HIV.
Cyanovirin-N (CV-N), an 11-kDa protein from the cyanobacterium
(blue-green algae) Nostoc ellipsosporum with potent
virucidal activity, was identified in the search for such antiviral
agents. The binding of CV-N to the heavily glycosylated HIV envelope
protein gp120 is carbohydrate-dependent. Since previous
CV-N-dimannose structures could not fully explain CV-N-oligomannose
binding, we determined the crystal structures of recombinant CV-N
complexed to Man-9 and a synthetic hexamannoside, at 2.5- and 2.4-Å
resolution, respectively. CV-N is a three-dimensional domain-swapped
dimer in the crystal structures with two primary sites near the hinge
region and two secondary sites on the opposite ends of the dimer. The
binding interface is constituted of three stacked
1
2-linked
mannose rings for Man-9 and two stacked mannose rings for hexamannoside with the rest of the saccharide molecules pointing to the solution. These structures show unequivocally the binding geometry of high mannose sugars to CV-N, permitting a better understanding of
carbohydrate binding to this potential new lead for the design of drugs
against AIDS.
*
This work was supported in part by federal funds from
the NCI, National Institutes of Health under Contract Number
N01-CO-12400.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1M5J, 1M5M) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).